Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2Masato Furuhashi, Gökhan S. Hotamışlıgil, Rex A. Parker et al.|Nature|2007Cited by 732
Discovery of 3-hydroxy-4-cyano-isoquinolines as novel, potent, and selective inhibitors of human 11β-hydroxydehydrogenase 1 (11β-HSD1)Shung Wu, Jeffrey A. Robl, David Yoon et al.|Bioorganic & Medicinal Chemistry Letters|2011Cited by 28
Discovery of Clinical Candidate 2-((2<i>S</i>,6<i>S</i>)-2-Phenyl-6-hydroxyadamantan-2-yl)-1-(3′-hydroxyazetidin-1-yl)ethanone [BMS-816336], an Orally Active Novel Selective 11β-Hydroxysteroid Dehydrogenase Type 1 InhibitorXiang‐Yang Ye, Jeffrey A. Robl, Stephanie Chen et al.|Journal of Medicinal Chemistry|2017Cited by 18
Synthesis and structure–activity relationship of 2-adamantylmethyl tetrazoles as potent and selective inhibitors of human 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1)Xiang‐Yang Ye, Jeffrey A. Robl, David Yoon et al.|Bioorganic & Medicinal Chemistry Letters|2013Cited by 17
Design, synthesis, and SAR studies of novel polycyclic acids as potent and selective inhibitors of human 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD-1)Xiang‐Yang Ye, Jeffrey A. Robl, Stephanie Chen et al.|Bioorganic & Medicinal Chemistry Letters|2011Cited by 12